Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1011220018Recruiting
Randomised trial in Impacted lower third molar comparing Levobupivacaine block with Placebo block (2 arms). Primary endpoints: Post-block pain intensity at 4 hours, Post-block pain intensity at 10 hours and 1 more. Started Sep 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1011220018.